PIK3CD and diffuse large B-cell lymphoma: In accord, our data show that the combination of PI3K pathway and BCL-2 inhibitors synergistically induce apoptosis in a panel of GCB-DLBCL cell lines, with dual PI3K/mTOR inhibition providing the greatest effect.